Ruengies - My unscientific translation would be either: 1) They screwed up in not specifying the trial correctly to the FDA or 2) They had to analyze the data differently than originally anticipated, thus invalidating the plan they had submitted to the FDA. P.S. I understand if you hoard your last reply of the day. :^)